With a promising treatment for Hepatitis C now available, health insurers have begun to limit its use, citing cost concerns. Insurers have put conditions on who can get the drug, while states like California and Texas have put the treatment on hold for further study. .
Last Updated on April 20, 2020 by Aimed Alliance
